GLP-1 Supplements and Natural GLP-1: What the Evidence Reports
What is in GLP-1 booster supplements like Lemme, Pendulum and Supergut, what the ingredient studies report, and what the FTC says about health claims.

Disclosure: PrescribedRX sells its own treatments, so we compete with some of the companies covered here, and we may earn affiliate commissions. PrescribedRX is a telehealth platform; prescriptions are written by licensed clinicians and filled by licensed partner pharmacies.
Short answer: A “GLP-1 supplement” is a dietary supplement, unlike prescription semaglutide and tirzepatide, and two brands covered below state on their own product pages that their products do not contain GLP-1 and are not GLP-1 drugs. The single-ingredient trials cited on this page enrolled 30 to 142 people for 8 weeks to 4 months, several were run by researchers tied to the ingredient’s maker, and they report changes in blood markers, glucose, snacking or weight.
What is a GLP-1 supplement?
A GLP-1 supplement is an over-the-counter product sold as a dietary supplement and marketed to “support” the body’s own GLP-1, a gut hormone. It is not the same thing as a prescription GLP-1 drug. Semaglutide (Wegovy) and tirzepatide (Zepbound) are prescription injections that act on GLP-1 receptors, and their prescribing information reports results from large placebo-controlled trials (Wegovy prescribing information; Zepbound prescribing information).
The brands say this themselves. Pendulum’s product page says its GLP-1 Probiotic “does not contain GLP-1 and is not a GLP-1 agonist drug” (Pendulum). Lemme’s page says Lemme Reset “does not contain GLP-1 or synthetic GLP-1 and is not a GLP-1 agonist drug” (Lemme).
Patches sold as “GLP-1” products are a separate story, covered in our guide to whether GLP-1 patches work.
What is in popular GLP-1 booster supplements?
Here is what three products marketed as GLP-1 supplements list, as shown on each brand’s site in October 2026. Formulas and prices change, so check the label before you buy.
| Product | What the brand lists | The brand’s GLP-1 wording | Price as listed |
|---|---|---|---|
| Lemme Reset GLP-1 Production Support Capsules | Per 2 capsules: Eriomin lemon fruit extract 200 mg, Supresa saffron extract 176.5 mg, Morosil red orange fruit extract 400 mg | “Supports your body’s natural GLP-1 levels”; “does not contain GLP-1 or synthetic GLP-1” | $80 one-time; $64 with monthly delivery |
| Pendulum GLP-1 Probiotic | Akkermansia muciniphila, Clostridium butyricum, Bifidobacterium infantis (amounts not shown on the page) | “Based on preclinical studies. Not intended for weight loss”; “does not contain GLP-1” | Not shown on the product page |
| Supergut GLP-1 Daily Support | Prebiotic fiber blend with resistant starch: oat beta glucan, Solnul resistant potato starch, unripened green banana, soluble vegetable fiber; 6 to 7 g fiber per serving | “Supports Natural GLP-1” | $60 (40 servings); smaller sizes from $32 |
Each page also carries its own fine print. Pendulum’s craving figures (91% and 88%) come from “a consumer survey of 274 people,” according to its page (Pendulum). Supergut footnotes its own pilot and observational studies and says “some results are based on self-reported data” (Supergut). Lemme’s page says its product “is not a weight loss supplement” (Lemme).
What do the studies report about each ingredient?
Lemon flavonoids (Eriomin)
Two trials from the same university group in Brazil tested Eriomin. In the first, 103 people with prediabetes took placebo or Eriomin (200, 400 or 800 mg a day) for 12 weeks. The authors reported blood glucose down 5% and GLP-1 up 15%, and they reported no change in body measurements such as weight (Phytother Res, 2019). In the second, 30 people with high blood sugar took 200 mg a day or placebo for 12 weeks each, in crossover. The authors reported glucose down 5% and GLP-1 up 17% (J Med Food, 2022).
Saffron extract
A 2010 trial gave 60 mildly overweight women a saffron extract called Satiereal (176.5 mg a day) or placebo for 8 weeks. The authors reported less frequent snacking and greater body weight reduction than placebo; the abstract does not give the amount of weight lost (Nutr Res, 2010). That study did not measure GLP-1. Lemme lists a different trade name, Supresa, at the same 176.5 mg dose, so this trial is not a test of Lemme’s ingredient.
Moro red orange extract
A 2026 meta-analysis pooled 3 randomized trials with 252 overweight adults and reported body weight 2.08 kg lower with Moro orange juice extract than with placebo. The authors said more research is needed on dose, duration and how it might work (Nutr Health, 2026). GLP-1 was not one of the outcomes.
Akkermansia and probiotic blends
Pendulum’s own researchers ran a 12-week trial in 76 adults with type 2 diabetes. A five-strain formula with inulin, including Akkermansia muciniphila, Clostridium butyricum and Bifidobacterium infantis, was reported to lower the glucose response after a test meal (-36.1 mg/dL/180 min, p=0.0500) and A1c (-0.6) compared with placebo. All authors were Pendulum employees and shareholders, and they called it a proof-of-concept study (BMJ Open Diabetes Res Care, 2020). That formula is not the same as the three-strain GLP-1 Probiotic.
Other Akkermansia trials used a pasteurized form. In a 2019 pilot (32 people completed), weight was 2.27 kg lower than placebo, a difference that was not statistically significant (P=0.091) (Nat Med, 2019). In a 2026 trial of 142 adults with metabolic syndrome, the main outcome, insulin sensitivity, did not differ from placebo; a rise in GLP-1 after a glucose drink showed up in exploratory analyses. Several authors work for or consult for The Akkermansia Company (Gut Microbes, 2026).
Berberine
A 2026 review notes that berberine has been popularized as “nature’s Ozempic” (Pharmaceuticals, 2026). A January 2026 meta-analysis of 23 articles on randomized trials reported body weight 0.88 kg lower with swallowed berberine than in control groups, and the authors called for better reporting of purity and potency (Int J Obes, 2026). A 2026 review describes berberine as an active drug-interaction risk, including effects on liver enzymes that process many medicines and added low blood sugar and low blood pressure effects (Pharmaceuticals, 2026). Our GLP-1 patch guide covers berberine in more depth.
Is there a best GLP-1 supplement?
We don’t rank them, because no trial has compared these products head to head. This table summarizes what each cited study reported:
| Ingredient | Study | People and length | GLP-1 measured? | What the study reported |
|---|---|---|---|---|
| Eriomin | Phytother Res 2019 | 103, 12 weeks | Yes | GLP-1 +15%, glucose -5%, no change in body measurements |
| Eriomin | J Med Food 2022 | 30, 12 weeks per phase | Yes | GLP-1 +17%, glucose -5% |
| Saffron (Satiereal) | Nutr Res 2010 | 60 women, 8 weeks | No | Less snacking; more weight reduction than placebo |
| Moro orange | Meta-analysis 2026 | 252, 3 trials | No | Weight 2.08 kg lower than placebo |
| Five-strain probiotic | BMJ Open DRC 2020 | 76, 12 weeks | No | Lower post-meal glucose and A1c; company-run |
| Pasteurized Akkermansia | Gut Microbes 2026 | 142, 4 months | Yes | Main outcome not met; GLP-1 rise in exploratory analysis |
| Berberine | Meta-analysis 2026 | 23 articles on randomized trials | No | Weight 0.88 kg lower than control groups |
Is there such a thing as natural GLP-1?
Yes, in the sense that GLP-1 is a hormone your own gut makes. “Natural GLP-1” products are supplements that claim to support that hormone, not sources of it. Of the studies above, the ones that measured GLP-1 reported changes in blood levels or in the rise after a glucose drink. The two Eriomin trials reported GLP-1 increases of 15% and 17%, and the 2019 trial reported no change in body measurements (Phytother Res, 2019).
What does the FTC say about supplement claims?
- FTC Health Products Compliance Guidance. The FTC says health benefit claims generally need “randomized, controlled human clinical testing” (FTC).
- Patches and gels. A 2026 review found 24 “natural GLP-1” patch products and 1 gel, none with posted certificates of analysis, and noted that supplements must be swallowed under the law (Ann Pharmacother, 2026).
How do supplement studies compare with prescription GLP-1 trials?
The prescribing information for the prescription drugs reports much larger and longer trials. In the 68-week STEP 1 trial, people on Wegovy 2.4 mg lost 14.9% of body weight on average vs 2.4% on placebo (Wegovy prescribing information). In the 72-week SURMOUNT-1 trial, average weight loss on Zepbound was 15.0% on 5 mg, 19.5% on 10 mg and 20.9% on 15 mg vs 3.1% on placebo (Zepbound prescribing information). These are trial averages for the branded drugs.
PrescribedRX offers compounded semaglutide and compounded tirzepatide, which are not the same products as Wegovy or Zepbound. The trial results above are for the branded drugs.
How do PrescribedRX GLP-1 plans work?
You complete a short online eligibility check; our GLP-1 eligibility guide explains the questions. A licensed provider reviews every intake, typically within 48 hours, and a prescription is issued only if a licensed provider determines treatment is appropriate. Your provider sets the dose. Prescriptions are written by state-licensed clinicians through Telegra MD and filled by licensed partner pharmacies, with free priority shipping. Plans are self-pay, and availability varies by state. Both medications are compounded. Compounded medications are prepared by licensed pharmacies and are not FDA-approved. Prices as shown on prescribedrx.com in October 2026:
| Plan | Price as shown on the site |
|---|---|
| Compounded semaglutide | 3 month plan $420 · $140/mo · Billed every 3 months. Cancel anytime. |
| Compounded tirzepatide | 3 month plan $597 · $199/mo · Billed every 3 months. Cancel anytime. |
For a wider look at self-pay prices, see GLP-1 prices without insurance.
When should you talk to a doctor?
If you take prescription medicines and are considering a supplement, talk to a licensed provider. Points from the sources on this page:
- The 2026 berberine review describes interactions through liver enzymes and drug transporters, plus added low blood sugar, low blood pressure and heart-rhythm (QT) effects (Pharmaceuticals, 2026).
- Lemme’s own label warning tells people who are pregnant, nursing, have a medical condition, have low blood sugar or take any medication to consult a physician (Lemme).
GLP-1 supplement FAQ
Do GLP-1 supplements contain GLP-1?
Not the ones covered here. Pendulum says its GLP-1 Probiotic “does not contain GLP-1 and is not a GLP-1 agonist drug,” and Lemme says Lemme Reset “does not contain GLP-1 or synthetic GLP-1.” Both are marketed to support the body’s own GLP-1 instead.
Want to know if a prescription GLP-1 is an option?
A prescription is issued only if a licensed provider determines treatment is appropriate, and your provider sets the dose. Take the eligibility quiz or explore compounded semaglutide and tirzepatide plans.
Sources
- Federal Trade Commission. Health Products Compliance Guidance. ftc.gov. Accessed Oct 2026.
- Ribeiro CB, et al. Effectiveness of Eriomin in managing hyperglycemia and reversal of prediabetes condition: a double-blind, randomized, controlled study. Phytother Res. 2019. PubMed. Accessed Oct 2026.
- Cesar TB, et al. Nutraceutical eriocitrin (Eriomin) reduces hyperglycemia by increasing glucagon-like peptide 1 and downregulates systemic inflammation: a crossover-randomized clinical trial. J Med Food. 2022. PubMed. Accessed Oct 2026.
- Gout B, et al. Satiereal, a Crocus sativus L extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women. Nutr Res. 2010. PubMed. Accessed Oct 2026.
- Campos CM, et al. Effect of Moro orange juice extract supplementation in weight management in adults: a systematic review and meta-analysis. Nutr Health. 2026. PubMed. Accessed Oct 2026.
- Perraudeau F, et al. Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation. BMJ Open Diabetes Res Care. 2020. PubMed. Accessed Oct 2026.
- Depommier C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019. PubMed. Accessed Oct 2026.
- Suenaert P, et al. Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome. Gut Microbes. 2026. PubMed. Accessed Oct 2026.
- The effect of berberine on obesity indices: a systematic review and meta-analysis. Int J Obes. January 2026. PubMed. Accessed Oct 2026.
- Dumitru CN, et al. Berberine-drug interactions: mechanisms, clinical relevance and risk stratification, a narrative review. Pharmaceuticals (Basel). 2026. PubMed. Accessed Oct 2026.
- White CM, Tai Z, Nuzi K. Transdermal “natural GLP-1” dietary supplements violate law and place patients at risk. Ann Pharmacother. 2026. PubMed. Accessed Oct 2026.
- Lemme. Lemme Reset GLP-1 Production Support Capsules, product page. lemmelive.com. Accessed Oct 2026.
- Pendulum. GLP-1 Probiotic, product page. pendulumlife.com. Accessed Oct 2026.
- Supergut. GLP-1 Daily Support, product page. supergut.com. Accessed Oct 2026.
- DailyMed. Wegovy (semaglutide) prescribing information. National Library of Medicine, NIH. dailymed.nlm.nih.gov. Accessed Oct 2026.
- DailyMed. Zepbound (tirzepatide) prescribing information. National Library of Medicine, NIH. dailymed.nlm.nih.gov. Accessed Oct 2026.
This article is for general information. It is not medical advice and it is not a recommendation for any particular treatment. Whether a treatment is appropriate for you is a decision for a licensed clinician who has reviewed your health history and current medications.
This article is for information only and is not medical advice. Treatment is prescribed solely at the discretion of a licensed provider following a clinical evaluation.



